bioRxiv Science⌕ Search

bioRxiv · 10.1101/720342

Computational Analysis of Energy Landscapes Reveals Dynamic Features that Contribute to Binding of Inhibitors to CFTR-Associated Ligand

Abstract

PDZ domains are small protein-binding domains that interact with short, mostly C-terminal peptides and play important roles in cellular signaling and the trafficking and localization of ion channels. The CFTR-associated ligand PDZ domain (CALP) binds to the cystic fibro-sis transmembrane conductance regulator (CFTR) and mediates degradation of mature CFTR through lysosomal pathways. Inhibition of the CALP:CFTR interaction has been explored as a potential therapeutic avenue for cystic fibrosis (CF).1 Previously, we reported2 the ensemble-based computational design of a novel 6-residue peptide inhibitor of CALP, which resulted in the most binding-efficient inhibitor of CALP to date. This inhibitor, kCAL01, was designed using OSPREY3 and displayed significant biological activity in in vitro cell-based assays. Here, we report a crystal structure of kCAL01 bound to CALP (PDB ID: 6OV7). To elucidate the structural basis for the enhanced binding efficiency of kCAL01, we compare this structure to that of a previously developed inhibitor of CALP, iCAL36 (PDB ID: 4E34). In addition to per-forming traditional structural analysis, we compute the side-chain energy landscapes for each structure using the recently developed MARK* partition function approximation algorithm.4 Analysis of these energy landscapes not only enables approximation of binding thermodynamics for these structural models of CALP:inhibitor binding, but also foregrounds important structural features and reveals dynamic features, both of which contribute to the comparatively efficient binding of kCAL01. The investigation of energy landscapes complements traditional analysis of the few low-energy conformations found in crystal structures, and provides information about the entire conformational ensemble that is accessible to a protein structure model. Finally, we compare the previously reported NMR-based design model ensemble for kCAL01 vs. the new crystal structure and show that, despite the notable differences between the CALP NMR model and crystal structure, many significant features are successfully captured in the design ensemble. This suggests not only that ensemble-based design captured thermodynamically significant features observed in vitro, but also that a design algorithm eschewing ensembles would likely miss the kCAL01 sequence entirely.\n\nGraphical TOC Entry\n\nO_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=82 SRC=\"FIGDIR/small/720342v1_ufig1.gif\" ALT=\"Figure 1\">\nView larger version (27K):\norg.highwire.dtl.DTLVardef@2a1036org.highwire.dtl.DTLVardef@18e5fe0org.highwire.dtl.DTLVardef@38ab86org.highwire.dtl.DTLVardef@84f1b5_HPS_FORMAT_FIGEXP M_FIG C_FIG

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Holt, G. T., Jou, J. D., Gill, N. P., Lowegard, A. U., Martin, J. W., Madden, D. R., Donald, B. R.. 2019-07-30. Computational Analysis of Energy Landscapes Reveals Dynamic Features that Contribute to Binding of Inhibitors to CFTR-Associated Ligand. https://doi.org/10.1101/720342

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The structures of two intermediates en route to DNA repair within a (6-4) photolyase

Pyrimidine (6-4) pyrimidone photoproducts (6-4PPs) are mutagenic DNA lesions produced when UV light crosslinks two adjacent pyrimidine bases. These lesions must be repaired to maintain genome integrity, a function executed by the (6-4) photolyase enzymes. This repair chemistry is complex, involving the transfer of a hydroxyl group from one base to another, accompanied or followed by cleavage of an interbase bond. It remains unclear how the enzyme orchestrates this reaction. Typically, models invoke a stepwise process in which an oxetane intermediate is transiently populated, but despite over thirty years of investigation, such an intermediate has never been definitively observed. Conducting dose-controlled X-ray crystallography on the (6-4) photolyase from Vibrio cholerae, we observed the transformation of 6-4PP into an oxetane species. Furthermore, we identified a previously unanticipated hemi-cleaved intermediate. The progressive transformation of 6-4PP into oxetane, hemi-cleaved, and fully repaired species requires a reexamination of the existing models of DNA repair by (6-4) photolyases.

biochemistry↗

Endothelial protein C receptor is an entry receptor for Langya virus

Langya virus (LayV) was recently discovered in infected individuals with febrile illness and classified as a Parahenipavirus, a group of poorly understood pathogens. LayV is distantly related to Nipah henipavirus which causes recurring outbreaks with case fatality rates reaching up to 90%. No vaccines or therapeutics are approved for use in humans for any parahenipavirus or henipavirus despite their broad geographic distribution and pandemic potential. Here, we discovered that human endothelial protein C receptor (EPCR) is an entry receptor for LayV and that the tetrameric LayV attachment glycoprotein (G) binds EPCR avidly. We reveal the molecular basis of LayV G recognition of the EPCR receptor and provide a blueprint of the determinants of receptor ortholog usage. We found that human and shrew EPCR orthologs promote cell entry of LayV and of the closely related Mojiang pseudoviruses. These results along with the detection of several Parahenipaviruses in shrews set these pathogens apart from Henipaviruses, which use Pteropid fruit bats as reservoir hosts. Our data support future surveillance efforts, by enabling prediction of EPCR utilization among newly discovered Parahenipaviruses, and the development and evaluation of countermeasures targeting this emerging group of human pathogens.

biochemistry↗

RNA-targeted aminopyridine compounds provide a new antifungal strategy

While RNA is an emerging therapeutic target class, progress is limited by a shortage of well-defined targets in which ligand binding is coupled to measurable function. The group I intron, a self-splicing ribozyme essential in fungal mitochondria but absent from humans, offers both a tractable platform for exploring first principles of small molecule-RNA targeting and a selective antifungal target. We recalibrated an intron-splicing assay to approximate cellular conditions and performed an extensive, cryo-EM-guided structure-activity relationship campaign against the Candida albicans mtLSU intron. Ligands containing a flexible diamine outperformed conformationally constrained analogues, suggesting a general principle for engaging dynamic RNA surfaces and yielding lead aminopyridine 56 (IC 21.6 nM). Compound 56 synergizes with amphotericin B against C. albicans, suggesting a path for combination therapies. RT-qPCR confirmed direct target engagement in cells. This work establishes the fungal group I intron as a viable, mechanistically distinct antifungal target and a model platform for RNA-targeted discovery.

biochemistry↗